glp 1 agonist retatrutide Eli Lilly's shows promising weight loss results in phase 3 trial Research shows GLP-1 receptor agonist

Description

Print it, email it to yourself, or save it in your SingleCare account for easy access

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Its release is also modulated by neuroendocrine and inflammatory signals integrated via the nucleus tractus solitarius in the brainstem, highlighting a key role of the central nervous system in regulating its secretion (Hjrne et al

BDNF, brain-derived neurotrophic factor

Therefore, studies that extend the follow-up time and increase the sample size to observe the role of GLP-1 in atherosclerosis can be further developed